ArticleHeliyon2024

Dihydroquercetin regulates HIF-1α/AKT/NR2B signalling to improve impaired brain function in rats with metabolic syndrome.

Yang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.